AstraZeneca will pay nearly a half-billion dollars to settle cases alleging its popular heartburn drugs damages the kidneys of users. The Cambridge, UK-based pharma giant will be paying $425 ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
The Commission and AstraZeneca settled a long dispute over coronavirus vaccine supply that will provide the bloc with 200 million doses by March 2022, they announced Friday. The drugmaker agreed to ...
Hyperkalemia (HK) is a chronic condition characterised by high levels of potassium in the blood. The Anglo-Swedish drugmaker ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn treatments for 425 million US dollars (£352 million). The FTSE 100 listed firm said the agreements will ...
